bempikibart — Topline data
H2 2027
Q32 Bio anticipates data from the Part B OLE in the second half of 2027.Source filing
QTTB biotech catalysts & pipeline
Q32 BIO INC · Data as of 2026-09-08
Upcoming catalysts
bempikibart — Conference presentation
H2 2026
Results from SIGNAL-AA Part B, including additional Week 36 data as well as initial findings from the off-drug period through Week 52, will be presented at a medical meeting in the second half of 2026.Source filing